Pharma-Bio Serv, Inc. Reports Earnings Results for the Full Year Ended October 31, 2020
February 01, 2021 at 06:06 am EST
Share
Pharma-Bio Serv, Inc. announced earnings results for the full year ended October 31, 2020. For the full year, the company announced sales was USD 21.564 million compared to USD 19.506 million a year ago. Operating income was USD 2.225 million compared to USD 1.696 million a year ago. Net income was USD 2.050 million compared to USD 2.087 million a year ago. Basic earnings per share from continuing operations was USD 0.089 compared to USD 0.09 a year ago.
Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The Company provides a range of compliance-related consulting services. The Company provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. The Company's technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The Company markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies in Puerto Rico, the United States, Europe and Brazil.
PHARMA-BIO SERV, INC. 
